Molecular basis of essential thrombocythaemia in humans and dogs – a review
<b>A potential cause of essential thrombocythaemia can be seen as the V617F point mutation within Janus kinase 2. This mutation occurs in 60-70% of patients with this disease and is located in the domain acting as an inhibitor. It increases the enzymatic activity of JAK2 kinase and induces int...
Guardado en:
Autores principales: | Nicola Padzik, Małgorzata Szewczuk |
---|---|
Formato: | article |
Lenguaje: | EN PL |
Publicado: |
Polish Society of Animal Production
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/9e1699cfd2e84ec78f01867596a1f248 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
A Comprehensive Genome-wide Analysis of Long Non-coding RNA and mRNA Expression Profiles of JAK2V617F-positive Classical Myeloproliferative Neoplasms
por: Jie Zhou, et al.
Publicado: (2021) -
FREQUENCY OF TET2 GENE MUTATION IN MYELOPROLIFERATIVE NEOPLASMS
por: Syed Owais Ali, et al.
Publicado: (2021) -
Janus kinase 2 mutations in cases with BCR-ABL-negative chronic myeloproliferative disorders from Turkey
por: Ismail Yildiz, et al.
Publicado: (2017) -
Dnmt3a is downregulated by Stat5a and mediates G0/G1 arrest by suppressing the miR-17-5p/Cdkn1a axis in Jak2V617F cells
por: Jie Zhou, et al.
Publicado: (2021) -
Clinical Characteristics and Management of Cerebral Venous Sinus Thrombosis in Patients with Essential Thrombocythemia
por: Jiao L, et al.
Publicado: (2021)